HC Sponsor LLC - Dec 22, 2021 Form 4 Insider Report for Hyperfine, Inc. (HYPR)

Role: 10%+ Owner
Signature: /s/ Christine Clarke, as Attorney-in-fact
Stock symbol: HYPR
Transactions as of: Dec 22, 2021
Transactions value $: $0
Form type: 4
Date filed: 12/27/2021, 08:10 PM
Next filing: Dec 20, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HYPR	Class A common stock	Conversion of derivative security		+5.53M			5.53M	Dec 22, 2021	Direct	F1, F2
transaction	HYPR	Class A Common Stock	Award		+1M	+18.07%		6.53M	Dec 22, 2021	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HYPR	Class A ordinary shares	Conversion of derivative security		-614K	-100%		0	Dec 22, 2021	Class A Ordinary Shares	614K		Direct	F1, F2
transaction	HYPR	Class B ordinary shares	Conversion of derivative security		-4.92M	-100%		0	Dec 22, 2021	Class A Ordinary Shares	4.92M		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Hyperfine, Inc., Liminal Sciences, Inc. and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), HealthCor domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hyperfine, Inc." ("Hyperfine"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of HealthCor, which were previously convertible into Class A ordinary shares of HealthCor, were automatically converted into shares of Class A common stock of Hyperfine, par value $0.0001 per share, on a one-for-one basis.
F2	This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by the Sponsor may be deemed to be beneficially held by HealthCor Group and Messrs. Cohen and Healey. Each such reporting person under this Form 4 disclaims beneficial ownership of the securities reported herein except to the extent of their respective pecuniary interest therein and the filing of this Form 4 shall not be construed as an admission that any such reporting person is the beneficial owner of any securities covered by this Form 4.
F3	The Reporting Persons have voting and dispositive power over the reported securities, which were acquired by affiliates of the Reporting Persons pursuant to a PIPE Investment in connection with the completion of the Business Combination.